The trial put herpes-infected patients into 7 groups, administering 6 dosage levels of GEN-003 and administering placebo to the final group. All but the weakest dose of GEN-003 demonstrated a statistically significant …
|
Genocea's herpes vaccine hits the mark in Phase II …
7
Like
Save
){kind=link}
Comments
Comments are disabled for this post.